Home Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
Article Open Access

Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker

  • Qin Le EMAIL logo , Niu Jianhua , Mulati , Xi Yu and He Jiageng
Published/Copyright: August 18, 2017

Abstract

Objective

To evaluate miR-25 expression in serum of gastric cancer (GC) patients and whether it can be a potential biomarker for GC diagnosis.

Methods

Forty one pathology confirmed GC patients and 41 healthy controls were included in this study. 10 mL peripheral venous blood were collected from GC patients and healthy controls. miR-25 relative expression and CA19-9 level in serum of GC patients and healthy controls were measured by real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR) and enzyme linked immunosorbent assay (ELISA), respectively. The diagnostic sensitivity, specificity and receiver operating characteristic (ROC) curve of serum miR-25 and CA19-9 were calculated by STATA11.0 software.

Results

The relative expression of miR-25 was 0.47±0.53 and 0.05±0.36 in serum of GC patients and healthy controls respectively with significant statistical difference (P<0.05). The serum level of CA19-9 for GC patients and healthy controls were 11.91±6.17 U/mL and 7.40±3.97 U/mL, indicating GC patients were much higher than those of healthy controls (P<0.05). The diagnostic sensitivity and specificity were 78.05% and 60.98% with the cut-off value of 0.32 for serum miR-25. Under this cut-off value, the area under the ROC curve was 0.75. For serum CA19-9, the diagnostic sensitivity and specificity were 70.73% and 56.10% with the cut-off value of 9.22 U/mL. Under this cut-off value, the area under the ROC curve was 0.73 with the 95% confidence interval of 0.62-0.84. Positive correlation was found between serum miR-25 relative expression and CA19-9 concentration of GC patients (r=0.75, P<0.05).

Conclusion

According to our present study, serum miR-25 was elevated in GC patients which may serve as a diagnostic biomarker for GC.

1 Introduction

Gastric cancer (GC) is rampant almost in every country all over the world [1]. In Japan GS is the most diagnosed malignant carcinoma in men [2]. In China mainland, GC is the 3rd leading cause of cancer related death [3]. More new cases of GS are found in China more than any other country each year and comprises nearly fifty percent of the global total GC patients. The general prognosis of GC is poor especially for China because of low early diagnosis rate [4]. Therefore, early detection of GC or effective screening for high risk patients is important to improve GC prognosis. Endoscopic biopsy and histopathological evaluation are known as the gold standard for GC diagnosis. However, highly expensive and relatively complex operating procedures makes these methods unsuitable for screening on a population basis, particularly for asymptomatic subjects.

Serum biomarkers are easy to access and usually used for GC diagnosis such as CEA, CA19-9, CA72-4 and et al [5, 6]. Recently, several studies have reported that some microRNAs were elevated or decreased in the serum of GC patients compared to healthy controls [7, 8]. These different expressed microRNAs may be potential biomarkers for GS diagnosis [7, 9, 10]. miR-25 is part of the miR-106b-25 cluster that was previously reported to be upregulated in several cancers tissues. However, its clinical value for gastric cancer diagnosis has not yet been reported. The objective of this study was to evaluate the serum miR-25 as a biomarker for gastric cancer diagnosis. Moreover, we further discussed the correlation between miR-25 level and CA19-9 concentration in serum of GC patients.

2 Material and methods

2.1 Patients and controls

Forty one GC patients with pathology confirmation were recruited in this study from Feb 2014 to Jan 2016. All the patients had pathology confirmation of gastric cancer. The patients did not receive any treatment such as chemotherapy, radiation or surgery before blood collection. For the included 41 GC patients, there was 24 male and 17 female subjects with the median age of 61(36 to 76) years old. The median age of the 41 healthy controls was 58 (33 to 81) years old with 22 male and 19 female. The general character of the 41 GC patients is demonstrated in Table 1. The research was approved by the Ethics Committee of 1st Affiliated Hospital of Shihezi University School of Medicine. Written informed consents were obtained from all of the patients.

Table 1

The clinical character of the included 41 GC patients

Charactern=41%
Gender
 Male2458.5
 Female1741.5
Age(years)
 <501843.9
 ≥502356.1
Tumor location
 Cardia1639.0
 Body of stomach1126.8
 Pylorus1434.1
Localregional lymph node metastasis
 Yes1639.0
 No2561.0
Pathology grading
 Well differentiation1024.4
 Moderate differentiation1434.1
 Poor differentiation1741.5

2.2 Serum collection

10mL peripheral venous blood was collected from GC patients and healthy controls from the basilic vein using clotting tubes, centrifuged at 3,000 rpm for 10 minutes at 4°C, and aliquoted into separate Eppendorf tubes. All samples were immediately frozen by liquid nitrogen and stored at -80°C until used.

2.3 MiR-25 detection

Total RNAs of the included GC patients and healthy controls were isolated by TRIzol reagent according to the manufacturer’s protocol. The isolated RNA was reverse-transcribed into gene cDNAs or miR-25 cDNAs by reverse transcription kit from Promega by using oligo(dT) n primer or miR-25 specific transcriptional primer. Realtime reverse transcription quantitative polymerase chain reaction (RT-qPCR) assay was performed by SYBR Green Realtime PCR Master Mix from Toyobo. The results were normalized against a-tubulin expression for genes and U6B expression for microRNAs. The RT-qPCR assay was performed in triplicate.

2.4 CA19-9 detection

Serum CA19-9 concentration of the two groups were determined by using commercial enzyme immunoassay kits (CA19-9; Dainabbot, Tokyo, Japan).

2.5 Statistical analysis

Data expressed as the mean±sd were analyzed by STATA11.0 software. The difference between GC patients and healthy controls was assessed by student-t test. Diagnostic sensitivity and specificity were calculated by the equation of sensitivity=true positive/(true positive + false negative), specificity = true negative / (true negative + false positive). The area under the ROC curve was used to evaluate the feasibility of serum miR-25 and CA19-9 as biomarkers for GC diagnosis. Pearson’s correlation test was performed to evaluate the relationship between the miR-25 relative expression and CA19-9 concentration in serum of GC patients. Two tailed P<0.05 was considered statistically significant.

3 Results

3.1 MiR-25 and CA19-9 expression in serum of GC patients and healthy controls

The serum level of MiR-25 and CA19-9 was detected by RT-qPCR or enzyme linked immunosorbent assay. As shown in Figure 1a, the relative expression level of miR-25 in serum of GC patients or healthy controls was 0.47±0.53 and 0.05±0.36, respectively, with significant difference (P<0.05). The serum CA19-9 level for GC patients and healthy controls was 11.91±6.17 U/mL versus 7.40±3.97 U/mL respectively, which indicates that the level in GC patients was much higher than that of healthy controls (P<0.05, Figure 1b).

Figure 1 MiR-25 and CA19-9 expression in serum of GC patients and healthy controls (a: mirR-25 relative expression in serum of GC and healthy controls; b: CA19-9 relative expression in serum of GC and healthy controls)
Figure 1

MiR-25 and CA19-9 expression in serum of GC patients and healthy controls (a: mirR-25 relative expression in serum of GC and healthy controls; b: CA19-9 relative expression in serum of GC and healthy controls)

Figure 2 The ROC analysis show the sensitivities and specificities of serum miR-25 and CA19-9 for GC diagnosis (a: serum miR-25 for diagnosis of GC; b: serum CA19-9 for diagnosis of GC).
Figure 2

The ROC analysis show the sensitivities and specificities of serum miR-25 and CA19-9 for GC diagnosis (a: serum miR-25 for diagnosis of GC; b: serum CA19-9 for diagnosis of GC).

Figure 3 Scatter plot demonstrates the positive correlation between miR-25 expression and CA19-9 concentrations in serum of GC
patients.
Figure 3

Scatter plot demonstrates the positive correlation between miR-25 expression and CA19-9 concentrations in serum of GC patients.

3.2 Diagnostic value of serum miR-25 and CA19-9

The diagnostic sensitivity and specificity were 78.05% and 60.98% with the cut-off value of 0.32 for serum miR-25. Under this cut-off value, the area under the ROC curve were was 0.75 with the 95% confidence interval of 0.640.85 (Figure 1a). For serum CA19-9, the diagnostic sensitivity and specificity were 70.73% and 56.10% with the cut-off value of 9.22 U/ml. Under this cut-off value, the area under the ROC curve were was 0.73 with the 95% confidence interval of 0.62-0.84, (Figure 1b).

3.3 Positive correlation or serum miR-25 and CA19-9

The diagnostic sensitivity and specificity were 78.05% and 60.98% with the cut-off value of 0.32 for serum miR-25. Under this cut-off value, the area under the ROC curve was 0.75 with the 95% confidence interval of 0.64-0.85 (Figure 1a). For serum CA19-9, the diagnostic sensitivity and specificity were 70.73% and 56.10% with the cut-off value of 9.22 U/ml. Under this cut-off value, the area under the ROC curve was 0.73 with the 95% confidence interval of 0.62-0.84 (Figure 1b).

4 Discussion

Gastric cancer (GC) is one of the most diagnosed malignant tumors world-wide especially in Japan and China. The general prognosis for GC is relatively good in Japan because of its effective methods for early diagnosis [11]. However, only a small percentage of patients, about 9 percent, are diagnosed with GC in the early stages even in some large medical centers. Early diagnosis of GC is even lower in some rural poor areas [4]. Therefore, cheap and convenient methods for early diagnoses of gastric cancer are badly needed which may improve the general prognosis of GC. The National Comprehensive Cancer Network (NCCN) gastric cancer guidelines describe several GC screening or early diagnosis procedures such as gastroscopy, barium meal test and other tests [12]. However, the highly expensive and relatively complex operating procedures make these methods unsuitable for screening on a population basis, particularly for asymptomatic subjects. So, the ideal gastric cancer screening or early diagnosis methods should be of high sensitivity, high specificity, cheap, non-invasive, and easy to operate [13]. Serum biomarkers are easy to access and widely used for GC diagnoses such as CEA, CA19-9, CA72-4, etc.[14-17]. However, the diagnostic sensitivity and specificity for a single biomarker is limited.

Mir-25 was a microRNA which was found to be differently expressed in serum of several kinds of malignant carcinomas compared to that of healthy people. This different expression between cancer and healthy controls makes it a potential biomarker for cancer diagnosis or screening. Deng T et al [18] identified circulating miR-25 as a potential biomarker for pancreatic cancer diagnosis. They found that miR-25 had significant diagnostic value for the differential diagnosis of pancreatic cancer from normal controls with an AUC of 0.915 (95% CI: 0.893-0.937) which was significantly higher compared with an AUC of 0.725 for serum tumor marker carcinoembryonic antigen (CEA).

We have searched the database of Pubmed and did not find studies about the diagnostic value of serum miR-25 for GC detection. Thus, we performed this work in order to evaluate the serum miR-25 as a biomarker for GC diagnosis. Moreover, we further discussed the correlation between miR-25 level and CA19-9 concentration in serum of GC patients. In our present study, we found that the diagnostic sensitivity and specificity were 78.05% and 60.98% with the cut-off value of 0.32 for serum miR-25. Under this cut-off value, the area under the ROC curve was 0.75. Positive correlation was found between serum miR-25 relative expression and CA19-9 concentration of GC patients (r=0.75, P<0.05). This study indicates that serum miR-25 is elevated in GC patients which may serve as a diagnostic biomarker for GC. However, the sample size is small with 82 participants which may decrease the statistical power. So, prospective multicenter diagnostic trials are need to further explicate the diagnostic value of serum miR-25 as a biomarker for GC diagnosis.

  1. Conflict of interest: No authors report any conflict of interest.

References

[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-3010.3322/caac.21332Search in Google Scholar PubMed

[2] Inoue M, Tsugane S. Epidemiology of gastric cancer in Japan. Postgrad Med J 2005;81:419-42410.1136/pgmj.2004.029330Search in Google Scholar PubMed PubMed Central

[3] Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115-13210.3322/caac.21338Search in Google Scholar PubMed

[4] Yan S, Li B, Bai ZZ, Wu JQ, Xie DW, Ma YC, Ma XX, Zhao JH, Guo XJ. Clinical epidemiology of gastric cancer in Hehuang valley of China: a 10-year epidemiological study of gastric cancer. World J Gastroenterol 2014;20:10486-1049410.3748/wjg.v20.i30.10486Search in Google Scholar PubMed PubMed Central

[5] Liang Y, Wang W, Fang C, Raj SS, Hu WM, Li QW, Zhou ZW. Clinical significance and diagnostic value of serum CEA, CA19-9 and CA72-4 in patients with gastric cancer. Oncotarget 2016;7:49565-4957310.18632/oncotarget.10391Search in Google Scholar PubMed PubMed Central

[6] Jagric T, Potrc S, Mis K, Plankl M, Mars T. CA19-9 serum levels predict micrometastases in patients with gastric cancer. Radiol Oncol 2016;50:204-21110.1515/raon-2015-0025Search in Google Scholar PubMed PubMed Central

[7] Wu D, Cao G, Huang Z, Jin K, Hu H, Yu J, Zeng Y. Decreased miR-503 expression in gastric cancer is inversely correlated with serum carcinoembryonic antigen and acts as a potential prognostic and diagnostic biomarker. Onco Targets Ther 2017;10:129-13510.2147/OTT.S114303Search in Google Scholar PubMed PubMed Central

[8] Meng X, Joosse SA, Müller V, Trillsch F, Milde-Langosch K, Mahner S, Geffken M, Pantel K, Schwarzenbach H. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients. Br J Cancer 2015;113:1358-136610.1038/bjc.2015.340Search in Google Scholar PubMed PubMed Central

[9] Li H, Wu Q, Li T, Liu C, Xue L, Ding J, Shi Y, Fan D. The miR-17-92 cluster as a potential biomarker for the early diagnosis of gastric cancer: evidence and literature review. Oncotarget 201710.18632/oncotarget.15023Search in Google Scholar PubMed PubMed Central

[10] Daneshpour M, Omidfar K, Ghanbarian H. A novel electrochemical nanobiosensor for the ultrasensitive and specific detection of femtomolar-level gastric cancer biomarker miRNA-106a. Beilstein J Nanotechnol 2016;7:2023-203610.3762/bjnano.7.193Search in Google Scholar PubMed PubMed Central

[11] Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, Inoue M. Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol 2011;17:4421-442810.3748/wjg.v17.i39.4421Search in Google Scholar PubMed PubMed Central

[12] Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016;14:1286-131210.6004/jnccn.2016.0137Search in Google Scholar PubMed

[13] Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics 2015;7:475-48610.2217/epi.15.4Search in Google Scholar PubMed

[14] Deng K, Yang L, Hu B, Wu H, Zhu H, Tang C. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients. PLoS One 2015;10:e012415110.1371/journal.pone.0124151Search in Google Scholar PubMed PubMed Central

[15] Tian SB, Yu JC, Kang WM, Ma ZQ, Ye X, Cao ZJ, Yan C. Combined detection of CEA, CA 19-9, CA 242 and CA 50 in the diagnosis and prognosis of resectable gastric cancer. Asian Pac J Cancer Prev 2014;15:6295-630010.7314/APJCP.2014.15.15.6295Search in Google Scholar

[16] Yang AP, Liu J, Lei HY, Zhang QW, Zhao L, Yang GH. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Clin Chim Acta 2014;437:183-18610.1016/j.cca.2014.07.034Search in Google Scholar PubMed

[17] Takata A, Kurokawa Y, Fujiwara Y, Nakamura Y, Takahashi T, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Mori M, Doki Y. Prognostic value of CEA and CK20 mRNA in the peritoneal lavage fluid of patients undergoing curative surgery for gastric cancer. World J Surg 2014;38:1107-111110.1007/s00268-013-2385-ySearch in Google Scholar PubMed

[18] Deng T, Yuan Y, Zhang C, Zhang C, Yao W, Wang C, Liu R, Ba Y. Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis. Cell Physiol Biochem 2016;39:1716-172210.1159/000447872Search in Google Scholar PubMed

Received: 2017-2-28
Accepted: 2017-3-30
Published Online: 2017-8-18

© 2017 Qin Le et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Regular Articles
  2. Intravascular treatment of left subclavian artery aneurysm coexisting with aortic coarctation in an adult patient
  3. Regular Articles
  4. Effect of electrical stimulation on blood flow velocity and vessel size
  5. Regular Articles
  6. Live birth pregnancy outcome after first in vitro fertilization treatment in a patient with Systemic Lupus Erythematosus and isolated high positive IgA anti-β2glycoprotein I antibodies: a case report
  7. Regular Articles
  8. Periodontal ligament stem cells regulate apoptosis of neutrophils
  9. Regular Articles
  10. Platelet-rich fibrin (PRF) in implants dentistry in combination with new bone regenerative flapless technique: evolution of the technique and final results
  11. Regular Articles
  12. The significance of strong ion gap for predicting return of spontaneous circulation in patients with cardiopulmonary arrest
  13. Regular Articles
  14. Clinicopathology of EpCAM and EGFR in human epithelial ovarian carcinoma
  15. Regular Articles
  16. Intraosseous lipoma of the mandibula: A case report and review of the literature
  17. Regular Articles
  18. Transurethral resection of the prostate, bladder explosion and hyponatremic encephalopathy: a rare case report of malpractice
  19. Regular Articles
  20. Brain strokes related to aortic aneurysma – the analysis of three cases
  21. Regular Articles
  22. Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
  23. Regular Articles
  24. Plasma free fatty acids in hyperemesis gravidarum pregnancy
  25. Regular Articles
  26. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia
  27. Regular Articles
  28. Gefitinib versus docetaxel in treated non-small-cell lung cancer: a meta-analysis
  29. Regular Articles
  30. The clinical characteristics of patients with chronic idiopathic anal pain
  31. Regular Articles
  32. Bone tunnel impaction reduced the tibial tunnel enlargement
  33. Regular Articles
  34. Effects of S-1 combined with radiotherapy in the treatment of nasopharyngeal cancer: a meta-analysis based on randomized controlled trials
  35. Regular Articles
  36. Predictions and outcomes of atrial fibrillation in the patients with acute myocardial infarction
  37. Regular Articles
  38. An accuracy study of the Intracavitary Electrocardiogram (IC-ECG) guided peripherally inserted central catheter tip placement among neonates
  39. Regular Articles
  40. Serum CA125, CA199 and CEA combined detection for epithelial ovarian cancer diagnosis: A meta-analysis
  41. Regular Articles
  42. Surface coil intensity correction in magnetic resonance imaging in spinal metastases
  43. Regular Articles
  44. Muscle stem cell and physical activity: what point is the debate at?
  45. Regular Articles
  46. MicroRNA let-7g directly targets forkhead box C2 (FOXC2) to modulate bone metastasis in breast cancer
  47. Regular Articles
  48. Monitoring health inequalities at the municipal level: Lithuanian experience
  49. Regular Articles
  50. Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
  51. Regular Articles
  52. Thrombectomy combined with indwelling-catheter thrombolysis is more effective than pure thrombectomy for the treatment of lower extremity deep venous thrombosis
  53. Regular Articles
  54. Expression of Hepcidin and Neogenin in colorectal cancer
  55. Regular Articles
  56. Carnitine and adiponectin levels in breast cancer after radiotherapy
  57. Regular Articles
  58. Pathophysiology of meningioma growth in pregnancy
  59. Regular Articles
  60. Causal neuro-immune relationships at patients with chronic pyelonephritis and cholecystitis. Correlations between parameters EEG, HRV and white blood cell count
  61. Regular Articles
  62. Measuring efficiency of secondary healthcare providers in Slovenia
  63. Regular Articles
  64. Galectin-3 expression in colorectal cancer and its correlation with clinical pathological characteristics and prognosis
  65. Regular Articles
  66. Model for studying anti- allergic drugs for allergic conjunctivitis in animals
  67. Regular Articles
  68. Barriers perceived by nurses in the optimal treatment of postoperative pain
  69. Regular Articles
  70. Tumor microenvironment in treatment of glioma
  71. Regular Articles
  72. Delirium risk of dexmedetomidine and midazolam in patients treated with postoperative mechanical ventilation: A meta-analysis
  73. Regular Articles
  74. Hemangioma of the rib: a rare case report and literature review
  75. Regular Articles
  76. The diagnostic accuracy of conventional forceps biopsy compared to ESD
  77. Regular Articles
  78. Increased miR-25 expression in serum of gastric cancer patients is correlated with CA19-9 and acts as a potential diagnostic biomarker
  79. Regular Articles
  80. Therapeutic nanomedicine surmounts the limitations of pharmacotherapy
  81. Regular Articles
  82. Relationship between PD-L1 expression and clinical characteristics in patients with breast invasive ductal carcinoma
  83. Regular Articles
  84. Trypsinogen activation peptide induces HMGB1 release from rat pancreatic acinar cells
  85. Regular Articles
  86. The effective regulation of pro- and anti-inflammatory cytokines induced by combination of PA-MSHA and BPIFB1 in initiation of innate immune responses
  87. Regular Articles
  88. Cell based therapeutic approach in vascular surgery: application and review
  89. Regular Articles
  90. Clinical efficacy of alprostadil combined with α-lipoic acid in the treatment of elderly patients with diabetic nephropathy
  91. Regular Articles
  92. Professional burnout and concurrent health complaints in neonatal nursing
  93. Regular Articles
  94. Esophageal xanthoma: presence of M2 macrophages suggests association with late inflammatory and reparative processes
  95. Regular Articles
  96. Cone beam computed tomography analysis in 3D position of maxillary denture
  97. Regular Articles
  98. CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis
  99. Regular Articles
  100. Serum AFU, 5’-NT and AFP as biomarkers for primary hepatocellular carcinoma diagnosis
  101. Regular Articles
  102. Absolute reliability and concurrent validity of hand held dynamometry and isokinetic dynamometry in the hip, knee and ankle joint: systematic review and meta-analysis
  103. Regular Articles
  104. The Fountain of Youth: A tale of parabiosis, stem cells, and rejuvenation
  105. Regular Articles
  106. Foam sclerotherapy during shunt surgery for portal hypertension and varices
  107. Regular Articles
  108. Insomnia and depression: Japanese hospital workers questionnaire survey
  109. Regular Articles
  110. Serum NF-κBp65, TLR4 as biomarker for diagnosis of preeclampsia
  111. Regular Articles
  112. Docetaxel/cisplatin therapy in myasthenia gravis with hypertension/diabetes
  113. Regular Articles
  114. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis
  115. Regular Articles
  116. Modified Sauve-Kapandji procedure for patients with old fractures of the distal radius
  117. Regular Articles
  118. Bile leakage after liver transplantation
  119. Regular Articles
  120. VEGF overexpression predicts poor survival in hepatocellular carcinoma
  121. Regular Articles
  122. Galen vein aneurysm– challenge for treatment
  123. Regular Articles
  124. Retrieval of a broken sewing needle from the sacrum aided by a permanent magnet: a case report and literature review
  125. Regular Articles
  126. HIV/STI prevention interventions: A systematic review and meta-analysis
  127. Regular Articles
  128. Aortic aneurysm as a complication of myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis
  129. Regular Articles
  130. Real-time monitoring of contrast-enhanced ultrasound for radio frequency ablation
  131. Regular Articles
  132. Successful drug-eluting stent implantation in a male patient with dextrocardia: a case report
  133. Regular Articles
  134. Primary pleomorphic liposarcoma of fallopian tube with recurrence: a case report and review of the literature
  135. Regular Articles
  136. Color Doppler Ultrasound in Uterine Arterial Embolization
  137. Regular Articles
  138. Pattern of alcohol consumption by young people from North Eastern Portugal
  139. Regular Articles
  140. Effects of out-of-hospital continuing nursing on schizophrenia patients' rehabilitation and quality of life
Downloaded on 5.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/med-2017-0040/html
Scroll to top button